Literature DB >> 23393387

Thioredoxin-interacting protein mediates sustained VEGFR2 signaling in endothelial cells required for angiogenesis.

Shin-Young Park1, Xi Shi, Jinjiang Pang, Chen Yan, Bradford C Berk.   

Abstract

OBJECTIVE: Thioredoxin-interacting protein (TXNIP) is an α-arrestin protein whose function is important for the regulation of vascular endothelial growth factor receptor 2 (VEGFR2) signaling and endothelial cell survival. Because VEGFR2 is critical for angiogenesis, we explored the role of TXNIP in VEGF-induced angiogenesis. APPROACH AND
RESULTS: TXNIP knockdown inhibited VEGF-induced endothelial cell tube formation and proliferation in cultured human umbilical vein endothelial cell. To elucidate the mechanism by which TXNIP altered VEGFR2 signaling in human umbilical vein endothelial cell, we studied phosphorylation of VEGFR2, phospholipase C gamma-1 (PLCγ1), endothelial NO synthase, and Akt (known as protein kinase B). TXNIP knockdown significantly decreased phosphorylation of VEGFR2 and PLCγ1 at times >5 minutes, but phosphorylation was unchanged at 2 minutes, as was Akt and endothelial NO synthase phosphorylation. Cell-surface biotinylation assay showed that TXNIP knockdown significantly attenuated VEGFR2 internalization. These results suggested that TXNIP was required for sustained VEGFR2 signaling, which is mediated largely by internalized VEGFR2. Rab5 knockdown to inhibit the trafficking and fusion of early endosomes significantly blocked VEGF-induced VEGFR2 internalization and phosphorylation of VEGFR2 and PLCγ1. Immunofluorescence and coimmunoprecipitation showed that TXNIP was part of a complex that included Rab5 and VEGFR2. Finally, TXNIP knockdown prevented the association of VEGFR2 and Rab5.
CONCLUSIONS: Our results show that TXNIP is essential for VEGFR2 internalization in Rab5 positive endosomes, which is required for endothelial cell growth and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23393387      PMCID: PMC3629821          DOI: 10.1161/ATVBAHA.112.300386

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  33 in total

1.  Oligomeric complexes link Rab5 effectors with NSF and drive membrane fusion via interactions between EEA1 and syntaxin 13.

Authors:  H M McBride; V Rybin; C Murphy; A Giner; R Teasdale; M Zerial
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

2.  Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-α: a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species.

Authors:  Cameron World; Oded N Spindel; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

Review 3.  Endocytosis and signaling.

Authors:  Harald W Platta; Harald Stenmark
Journal:  Curr Opin Cell Biol       Date:  2011-04-05       Impact factor: 8.382

Review 4.  VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis.

Authors:  Alexander F Bruns; Leyuan Bao; John H Walker; Sreenivasan Ponnambalam
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

5.  The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.

Authors:  Sarah J Welsh; William T Bellamy; Margaret M Briehl; Garth Powis
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

6.  Grb10 prevents Nedd4-mediated vascular endothelial growth factor receptor-2 degradation.

Authors:  Joseph Murdaca; Caroline Treins; Marie-Noëlle Monthouël-Kartmann; Rodolphe Pontier-Bres; Sharad Kumar; Emmanuel Van Obberghen; Sophie Giorgetti-Peraldi
Journal:  J Biol Chem       Date:  2004-04-01       Impact factor: 5.157

Review 7.  Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects.

Authors:  Ian Zachary; Robert D Morgan
Journal:  Heart       Date:  2010-09-30       Impact factor: 5.994

Review 8.  VEGF-A splicing: the key to anti-angiogenic therapeutics?

Authors:  Steven J Harper; David O Bates
Journal:  Nat Rev Cancer       Date:  2008-10-16       Impact factor: 60.716

Review 9.  Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition.

Authors:  Katherine Holmes; Owain Ll Roberts; Angharad M Thomas; Michael J Cross
Journal:  Cell Signal       Date:  2007-06-12       Impact factor: 4.315

10.  Rab GTPase regulation of VEGFR2 trafficking and signaling in endothelial cells.

Authors:  Helen M Jopling; Adam F Odell; Nigel M Hooper; Ian C Zachary; John H Walker; Sreenivasan Ponnambalam
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04-16       Impact factor: 8.311

View more
  20 in total

1.  Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet.

Authors:  Islam N Mohamed; Sherif S Hafez; Arwa Fairaq; Adviye Ergul; John D Imig; Azza B El-Remessy
Journal:  Diabetologia       Date:  2013-11-08       Impact factor: 10.122

2.  A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells.

Authors:  Sukhbir Kaur; Abdel G Elkahloun; Satya P Singh; Anush Arakelyan; David D Roberts
Journal:  J Cell Commun Signal       Date:  2017-11-29       Impact factor: 5.782

3.  Constitutive Endocytosis of VEGFR2 Protects the Receptor against Shedding.

Authors:  Dimitris Basagiannis; Savvas Christoforidis
Journal:  J Biol Chem       Date:  2016-06-13       Impact factor: 5.157

Review 4.  Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit.

Authors:  Islam N Mohamed; Tauheed Ishrat; Susan C Fagan; Azza B El-Remessy
Journal:  Antioxid Redox Signal       Date:  2014-11-11       Impact factor: 8.401

Review 5.  Redox Regulation via Glutaredoxin-1 and Protein S-Glutathionylation.

Authors:  Reiko Matsui; Beatriz Ferran; Albin Oh; Dominique Croteau; Di Shao; Jingyan Han; David Richard Pimentel; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2020-01-23       Impact factor: 8.401

6.  Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.

Authors:  Candice Chapouly; Azeb Tadesse Argaw; Sam Horng; Kamilah Castro; Jingya Zhang; Linnea Asp; Hannah Loo; Benjamin M Laitman; John N Mariani; Rebecca Straus Farber; Elena Zaslavsky; German Nudelman; Cedric S Raine; Gareth R John
Journal:  Brain       Date:  2015-03-23       Impact factor: 13.501

7.  Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells.

Authors:  Mohammed A Abdelsaid; Suraporn Matragoon; Azza B El-Remessy
Journal:  Antioxid Redox Signal       Date:  2013-07-12       Impact factor: 8.401

8.  Thioredoxin-interacting protein is a biomechanical regulator of Src activity: key role in endothelial cell stress fiber formation.

Authors:  Oded N Spindel; Ryan M Burke; Chen Yan; Bradford C Berk
Journal:  Circ Res       Date:  2014-02-10       Impact factor: 17.367

Review 9.  Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.

Authors:  Sanaz Nasoohi; Saifudeen Ismael; Tauheed Ishrat
Journal:  Mol Neurobiol       Date:  2018-02-27       Impact factor: 5.590

10.  Regulation of β-adrenergic receptor trafficking and lung microvascular endothelial cell permeability by Rab5 GTPase.

Authors:  Junjun Yang; Huan Sun; Jihang Zhang; Mingdong Hu; Jianchun Wang; Guangyu Wu; Guansong Wang
Journal:  Int J Biol Sci       Date:  2015-06-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.